Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison between obese and non-obese nonalcoholic fatty liver disease. | Clin Mol Hepatol | 2023 | 36472052 | PubTator, text mining | PubMed |
| Artificial intelligence model with deep learning in nonalcoholic fatty liver disease diagnosis: genetic based artificial neural networks. | Nucleosides Nucleotides Nucleic Acids | 2023 | 36448439 | PubTator, text mining | PubMed |
| Screening strategy for non-alcoholic fatty liver disease. | Clin Mol Hepatol | 2023 | 36447420 | PubTator, text mining | PubMed |
| In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations. | Cell Mol Gastroenterol Hepatol | 2023 | 36442812 | PubTator, text mining | PubMed |
| Associations of selenoprotein expression and gene methylation with the outcome of clear cell renal carcinoma. | Arch Biochem Biophys | 2023 | 36442530 | PubTator, text mining | PubMed |
| Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review. | Infect Dis Ther | 2023 | 36441483 | PubTator, text mining | PubMed |
| Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis. | J Hepatol | 2023 | 36427656 | PubTator, text mining | PubMed |
| Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease. | Clin Mol Hepatol | 2023 | 36417893 | PubTator, text mining | PubMed |
| Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort. | J Cachexia Sarcopenia Muscle | 2023 | 36403577 | PubTator, text mining | PubMed |
| What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease? | Ann Hepatol | 2023 | 36371078 | PubTator, text mining | PubMed |
| Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis. | J Hepatol | 2023 | 36368598 | PubTator, text mining | PubMed |
| Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma. | Clin Mol Hepatol | 2023 | 36353768 | PubTator, text mining | PubMed |
| Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD. | Aliment Pharmacol Ther | 2023 | 36349732 | PubTator, text mining | PubMed |
| N-end Rule-Mediated Proteasomal Degradation of ATGL Promotes Lipid Storage. | Diabetes | 2023 | 36346641 | PubTator, text mining | PubMed |
| Noninvasive tests for nonalcoholic fatty liver disease in a multi-ethnic population: The HELIUS study. | Hepatol Commun | 2023 | 36333949 | PubTator, text mining | PubMed |
| Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease. | Annu Rev Pathol | 2023 | 36270295 | PubTator, text mining | PubMed |
| Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. | Nat Rev Gastroenterol Hepatol | 2023 | 36258033 | PubTator, text mining | PubMed |
| Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic Steatohepatitis. | J Clin Gastroenterol | 2023 | 36251413 | PubTator, text mining | PubMed |
| Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis. | Clin Mol Hepatol | 2023 | 36226471 | PubTator, text mining | PubMed |
| A proteome-scale map of the SARS-CoV-2-human contactome. | Nat Biotechnol | 2023 | 36217029 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=49